NDC 81643-9270

Floxuridine

Floxuridine

Floxuridine is a Intra-arterial Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Cerona Therapeutics, Inc.. The primary component is Floxuridine.

Product ID81643-9270_1655283e-30b3-4267-b775-33ed0b6999a9
NDC81643-9270
Product TypeHuman Prescription Drug
Proprietary NameFloxuridine
Generic NameFloxuridine
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRA-ARTERIAL
Marketing Start Date2022-06-09
Marketing CategoryANDA /
Application NumberANDA075387
Labeler NameCerona Therapeutics, Inc.
Substance NameFLOXURIDINE
Active Ingredient Strength500 mg/1
Pharm ClassesAntimetabolite [EPC], Deoxyuridine [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 81643-9270-1

1 VIAL in 1 BOX, UNIT-DOSE (81643-9270-1) > 5 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
Marketing Start Date2022-06-09
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Floxuridine" or generic name "Floxuridine"

NDCBrand NameGeneric Name
0143-9270FloxuridineFloxuridine
63323-145FloxuridineFLOXURIDINE
81643-9270FloxuridineFloxuridine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.